Journey Strategic Wealth’s MetLife MET Stock Holding History

Journey Strategic Wealth’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,502	Closed	-$206K	–	802
2025 Q3	$206K	Sell	2,502 -461	-16%	-$36.3K	0.01%	663
2025 Q2	$238K	Buy	+2,963	New	+$229K	0.01%	528

Other funds holding MET

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Journey Strategic Wealth's MET Position: Q4 2025 in Review

Journey Strategic Wealth sold out of MetLife (MET) in Q4 2025, closing a stake of 2,502 shares — an estimated $206K sold.

Journey Strategic Wealth first reported a position in MET in Q2 2025 and held it in 2 quarters. The position peaked at $238K in Q2 2025. 1,440 funds tracked by Wall St. Rank hold MET as of Q4 2025.

Journey Strategic Wealth reported no remaining MetLife position as of Q4 2025 after selling out during the quarter.
Journey Strategic Wealth sold 2,502 MetLife shares in Q4 2025, an estimated $206K.
Journey Strategic Wealth first reported a position in MetLife in Q2 2025 and held it in 2 quarters.
Journey Strategic Wealth's MetLife position peaked at $238K in Q2 2025.
1,440 funds tracked by Wall St. Rank held MetLife as of Q4 2025.

Based on Journey Strategic Wealth's 13F filing for Q4 2025, filed 13 Feb 2026.